🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
This will be a multicenter, prospective, randomized, open-label trial with ...
Status
Recruiting
Location
UFMG
Start Date
2026-03-04
Trial ID
NCT07463235
Treatments Being Tested
The researchers are doing this study to measure and test cell-free DNA (cfD...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Start Date
2020-07-08
Trial ID
NCT04468841
This will be a multistate, multicenter clinical study to determine the effi...
Status
Unknown
Location
OMNI Medical Services
Start Date
2018-12-01
Trial ID
NCT03944447
Treatments Being Tested
Screening patients who meet the criteria for peripheral blood mononuclear c...
Status
Recruiting
Location
The Obstetrics and Gynecology Hospital of Fudan University
Start Date
2025-05-11
Trial ID
NCT06904131
Treatments Being Tested
The Outreach Core (OC) of the Ponce Health Sciences University-Moffitt Canc...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2023-03-22
Trial ID
NCT05832177
Treatments Being Tested
This is a randomized clinical trial (RCT) to assess the efficacy of bariatr...
Status
Terminated
Location
Boston Medical Center
Start Date
2022-10-03
Trial ID
NCT05156762
Patients will take 150 mg of GSE product by mouth twice daily and will be e...
Status
Completed
Location
University of Colorado Cancer Center
Start Date
2018-01-18
Trial ID
NCT03087903
Treatments Being Tested
The purpose of this research study is to test the safety and efficacy of a ...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2026-02-02
Trial ID
NCT07148180
Treatments Being Tested
Oculgen has begun a study of an investigational drug called OCUL101 as a po...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-17
Trial ID
NCT07520318
Treatments Being Tested